BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14691454)

  • 1. Immunological and pathobiological roles of fibulin-1 in breast cancer.
    Pupa SM; Argraves WS; Forti S; Casalini P; Berno V; Agresti R; Aiello P; Invernizzi A; Baldassari P; Twal WO; Mortarini R; Anichini A; Ménard S
    Oncogene; 2004 Mar; 23(12):2153-60. PubMed ID: 14691454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to fibulin-1 generated by genetic immunization.
    Pupa SM; Forti S; Invernizzi AM; Giovanazzi R; Twal WO; Argraves WS; Ménard S
    J Cell Biochem; 2003 Jul; 89(4):647-52. PubMed ID: 12858331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
    Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
    Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of breast cancer response to chemotherapy by fibulin-1.
    Pupa SM; Giuffré S; Castiglioni F; Bertola L; Cantú M; Bongarzone I; Baldassari P; Mortarini R; Argraves WS; Anichini A; Menard S; Tagliabue E
    Cancer Res; 2007 May; 67(9):4271-7. PubMed ID: 17483339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.
    Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL
    Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
    Wen YH; Shi X; Chiriboga L; Matsahashi S; Yee H; Afonja O
    Oncol Rep; 2007 Dec; 18(6):1387-93. PubMed ID: 17982621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS; Jung MY; Cho D; Cohen EP
    Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.
    Madjd Z; Parsons T; Watson NF; Spendlove I; Ellis I; Durrant LG
    Breast Cancer Res; 2005; 7(5):R780-7. PubMed ID: 16168124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A7 (psoriasin) influences immune response genes in human breast cancer.
    Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
    Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue.
    Motalebzadeh J; Mahjoubi F; Nafissi N; Hashemian M; Taheri M; Hosseinpour Y
    Cancer Biomark; 2017; 19(1):51-55. PubMed ID: 28282800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
    Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.